MFDS — authorised 18 May 2023
- Marketing authorisation holder: BAUSCH AND LOMB INC
- Status: likely_approved
🇰🇷 Miebo in South Korea
MFDS authorised Miebo on 18 May 2023
Marketing authorisation
Miebo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Ophthalmology approved in South Korea
Frequently asked questions
Is Miebo approved in South Korea?
Yes. MFDS authorised it on 18 May 2023.
Who is the marketing authorisation holder for Miebo in South Korea?
BAUSCH AND LOMB INC holds the South Korean marketing authorisation.